ScholarLens Back to search
2006•Strait Pharmaceutical JournalRequires access

Cost-effectiveness Analysis of Three Therapeutic Schemes for Lower Respiratory Tract Infections

Yang Zhao-you

Open publisher page 0 citations

Abstract

OBJECTIVE To diccuss the economic effects of different antibiotic on the treatment of same illness.METHODS 210 cases of lower respiratory tract infections(LRTI) were randomly divided into three groups,azithromycin was to given to the group A,clindamycin phosphate to the group B,and amoxicillin/clavulanate potassium to the group C.And data was evaluated using the pharmacoeconomic cost-effectiveness analysis.RESULTS The antimicrobial costs of three schemes were RMB 640.00yuan,760.00yuan,and 1328.00yuan and the effective rate were82.85%、80.00%、81.42% respectively.CONCLUSION According to the evaluation with pharmaconomic cost-effectiveness analysis,A is the best therapeutic regime.

About this research paper

What this paper is about

OBJECTIVE To diccuss the economic effects of different antibiotic on the treatment of same illness.METHODS 210 cases of lower respiratory tract infections(LRTI) were randomly divided into three groups,azithromycin was to given to the group A,clindamycin phosphate to the group B,and amoxicillin/clavulanate potassium to the group C.And data was evaluated using the pharmacoeconomic cost-effectiveness analysis.RESULTS The antimicrobial costs of three schemes were RMB 640.00yuan,760.00yuan,and 1328.00yuan and the effective rate were82.85%、80.00%、81.42% respectively.CONCLUSION According to the evaluation with pharmaconomic cost-effectiveness analysis,A is the best therapeutic regime.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To diccuss the economic effects of different antibiotic on the treatment of same illness.METHODS 210 cases of lower respiratory tract infections(LRTI) were randomly divided into three groups,azithromycin was to given to the group A,clindamycin phosphate to the group B,and amoxicillin/clavulanate potassium to the group C.And data was evaluated using the pharmacoeconomic cost-effectiveness analysis.RESULTS The antimicrobial costs of three schemes were RMB 640.00yuan,760.00yuan,and 1328.00yuan and the effective rate were82.85%、80.00%、81.42% respectively.CONCLUSION According to the evaluation with pharmaconomic cost-effectiveness analysis,A is the best therapeutic regime.

Key concepts: Medicine, Azithromycin, Amoxicillin, Respiratory tract infections, Internal medicine, Lower respiratory tract infection, Antibiotics, Clindamycin

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Cost-effectiveness Analysis of Three Therapeutic Schemes for Lower Respiratory Tract Infections — Research Paper | ScholarLens